Radiation enhancing hafnium oxide nanoparticles (NBTXR3) for the treatment of cisplatin-ineligible locally advanced HNSCC patients: a phase I dose expansion study. (July 2021) - Tourneau, Christophe Le; Calugaru, Valentin; Moreno, Victor; Calvo, Emiliano; Liem, Xavier; Salas, Sébastien; Doger, Bernard; Jouffroy, Thomas; Mirabel, Xavier; Rodriguez, Jose; Chilles, Anne; Bernois, Katell; et al.